Relbovin 50 Injection
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Vinorelbine (50mg)
Overview Relbovin 50 Injection
Oncaspar 50 Injection is a chemotherapeutic agent indicated for breast and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to the prescribed regimen is crucial, as improper use or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent immediately; discontinuation should only occur under medical supervision. Common side effects include nausea, emesis, asthenia, lassitude, and alopecia. This medication can suppress hematopoiesis, potentially increasing infection risk, necessitating regular blood counts and monitoring of cardiac, hepatic, and uric acid levels. Prior to commencing treatment, inform your doctor of any pre-existing cardiac, hepatic, or renal conditions, or concurrent use of anti-infectives. Drug interactions are possible; disclose all medications to your physician. This treatment is contraindicated during pregnancy and lactation; effective contraception is mandatory for both partners. Male patients should consult with their physician regarding sperm banking prior to therapy initiation.
Uses of Relbovin 50 Injection
Carcinoma of the breast | Lung cancer (excluding small cell)
Major Benefits of Relbovin 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Relbovin 50 Injection:
- Nausea
- Vomiting
- Weakness
- Fatigue
- Hair loss
- Low blood platelets
- Increased liver enzymes
- Fever
- Anemia (low number of red blood cells)
- Bleeding
- Constipation
How to use Relbovin 50 Injection:
The medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
How Relbovin 50 Injection works:
Relbovin 50 Injection inhibits DNA replication within cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Relbovin 50 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Relbovin 50 Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Relbovin 50 Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingSAFE
Relbovin 50 Injection typically has no impact on driving capabilities.
KidneySAFE IF PRESCRIBED
Relbovin 50 Injection presents no known safety concerns for individuals with kidney conditions; dosage modification is not typically necessary. Nevertheless, consultation with a physician is advised for patients with pre-existing kidney disease.
LiverCAUTION
For individuals with hepatic impairment, Relbovin 50 Injection requires careful administration. Dosage modification of Relbovin 50 Injection may be necessary. Physician consultation is recommended. Routine monitoring of liver function is advisable during treatment.
What if you forget to take Relbovin 50 Injection :
NA
Facts to Know About Relbovin 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Vinca-derived anti-cancer agents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Vinca alkaloid antimicrotubule agents |
3,018 People bought this recently